Introduction
There is growing interest in the role of free-radical Alzheimer's disease (AD) and Parkinson's disease (PD).4-6 damage in neoplasia, vascular disease, neurodegenerative disease and ageing.1 The brain is an ideal Since a few free radicals are potentially sufficient to damage severely a large number of cells, there target for free-radical damage. It is composed of large quantities of lipids which make an excellent are counter-mechanisms to prevent and repair damage. Such mechanisms include antioxidants. One substrate for free-radical reactions. It has rich reserves of iron which catalyse such reactions, and has a major antioxidant system is the exogenous chainbreaking antioxidants, which inhibit free-radicalhigh energy demand which is satisfied by a high metabolic turnover and oxidative reactions in brainmediated chain reactions, and include vitamin E (atocopherol), vitamin C, b-carotene and a number of cell mitochondria. Electrons can leak from the mitochondrial respiratory chain, attach themselves to other less important compounds. The most important lipid-phase antioxidant is a-tocopherol, which is molecules and form free radicals. Therefore, the brain provides a site where substrate, free radicals found in lipid membranes and low-density lipoprotein (LDL) particles. and catalyst are brought together in close proximity.2,3 Evidence has accumulated that free radical Plasma levels of chain-breaking antioxidants can be measured and, providing that the subject has injury may contribute to the pathogenesis of adequate nutrition, should reflect oxidative activity clinics (Neurology and Elderly Care) and Geriatric Day Hospital, Belfast City Hospital. PD and PDem in the body. However, the collective individual measurement of these antioxidants is costly and timepatients with concomitant disease and or atypical features were excluded. A diagnosis of PD was made consuming. In addition, there appears to be synergism between antioxidants, and a summation of in accordance with the UKPDSBB criteria15 and dementia was established using MMSE and DSM III individual measurements may not accurately reflect the total antioxidant effect. A measure of total R criteria.16 Since the PD group were significantly younger than those with dementia, additional antioxidant capacity. (TAC) may be a more efficient method of measuring antioxidant status of subjects, younger controls were recruited from retirement clubs and from younger people who have previously and several such assays are described.7
The aim of this study was to establish whether assisted in departmental research. Subjects were excluded from the study if haemoincreased oxidation was evident as a reduction in individual plasma chain-breaking antioxidants globin or albumin levels were below normal ranges quoted in the Laboratory, Belfast City Hospital. In and TAC in AD, VaD, PDem and PD. We also wished to establish, in these diseases, whether indithe case of haemoglobin, values lower than 12.5 g/dl for males and 11.5 g/dl for females were excluded vidual antioxidant changes were reflected in TAC.
and serum albumin <35 g/l was also excluded.
Other exclusion criteria included any serious concomitant disease, including diabetes mellitus, and Methods significant gastrointestinal disease, and ingestion of vitamin supplements. The study was approved by the local ethical committee. All subjects were recruited and assessed by the Three hundred and fifty subjects were screened for this study. Seventy-one were excluded on the same physician, trained in the use of the scales and familiar with the diagnostic criteria. Written informed grounds of low haemoglobin or albumin levels. The majority of those excluded were patients with demenconsent was obtained from subjects and carers prior to inclusion in the study. Patients were recruited tia. A further 28 samples were unsuitable for analysis. Antioxidant assays were not performed on excluded from the Memory Clinic and Day Hospital, Belfast City Hospital, and from the Alzheimer's Disease subjects. A total of 251 subjects were included (23 of the dementia control group were suitable for Society. Dementia patients were assessed using a structured interview and examination that included controls in the PD control group). Five ml of EDTA-anticoagulated blood was taken the Folstein Mini Mental State Examination (MMSE), 8 Geriatric Depression Scale,9 Barthel index of activitfrom each subject for antioxidant analysis. The blood was centrifuged immediately, plasma separated and ies of daily living10 and the Hachinski Ischaemic Scale.11 Dementia subjects were living in the comdivided into 0.5 ml aliquots. An equal measure (0.5 ml) of 10% metaphosphoric acid was added to munity with a cognitively-intact carer who was responsible for preparation of meals. All participants/ one plasma aliquot, vortex-mixed and stored for ascorbic acid analysis. Plasma samples were frozen carers were specifically questioned about diet, which had to comprise three meals a day, one of which and stored at −70°C until immediately before analysis. included meat and vegetables. A full and detailed nutritional assessment was not performed. A blood Subject types were mixed during sampling to reduce the effect of variations in sampling technique. screen for systemic causes of dementia, including a full blood picture, liver, renal and thyroid function Samples were stored and subsequently analysed in batches. To minimize bias and the effect of variation tests, a C-reactive protein, B12 and folate, and syphilitic serology was analysed and CT scan of in laboratory analysis, each batch contained a mix of subject types, and technicians analysing the brain performed. Diagnoses were made as probable AD and probable VaD according to samples were unaware of diagnoses.
The following plasma antioxidants were measured the DSM IV,12 NINCDS ADRDA,13 and AIREN14 criteria, respectively. Mixed and other forms of and compared between subject groups: a-carotene, b-carotene, lycopene, vitamin A, vitamin C, vitamin dementia except PDem were excluded. Patients included had mild to moderate dementia E, vitamin E corrected for cholesterol, urate, bilirubin, total antioxidant capacity. (MMSE>10 and ∏24), were physically well, and living in the community. Control subjects were Retinol, a-tocopherol, a-carotene, b-carotene and lycopene were determined simultaneously using recruited from retirement clubs and from volunteers who have helped in other studies within the a HPLC method.17 Intra-and inter-batch CVs for all assays were <8% and <10%, respectively. Department. These were cognitively intact and had no serious or unstable medical condition.
Plasma vitamin C measurement was made by a fluorimetric assay using a centrifugal analyser with Patients with PD were recruited from out-patient fluorescent attachment.18 Intra-and inter-batch CVs No significant difference in cholesterol-corrected vitamin E or TAC was detected ( Table 2 ). were 1.7% and 2.5%, respectively.
The TAC assay measures the inhibitory effect of The statistical analysis for the comparisons between dementia groups and controls is shown in antioxidants in plasma or other biological fluids when added to a reaction generating water-soluble The only difference between PD and controls was Urate, cholesterol and bilirubin were measured using standard laboratory techniques on a Kodak a significant reduction in bilirubin in PD (Table 4 ). Extrachem analyser.
As distributions of the resulting data were skewed, non-parametric methods of analysis were used.
Discussion
Kruskal-Wallis I Way Analysis of Variance (ANOVA)
This study demonstrates a significant depletion of was used to describe the significant changes in specific chain-breaking antioxidants in the dementia variables. The Mann-Whitney Wilcoxon Rank Sum groups studied. No significant changes in these W Test was used in post-hoc analyses, and describes antioxidants were demonstrated in PD. There was the significance of these changes between groups.
also no significant change in the total antioxidant This test was only performed on those variables measure TAC for any group in this study. showing significance in the ANOVA. The MannVitamins A, C and E were depleted in AD comWhitney/Wilcoxon Rank Sum W Test was also used pared to controls. Vitamins A, C and b-carotene in the comparison of PD and respective controls.
were also significantly reduced in the VaD group Significance was accepted at the 5% level.
when compared to controls. b-carotene was lower in VaD than in AD. Vitamin C and lycopene were depleted in PDem compared to controls. Lycopene
Results
was also significantly decreased in PDem compared to AD and VaD. Dementia, PD and control populations are described in Table 1 . The values for the variables studied are Changes in antioxidants have been observed in small studies of dementia subjects. Plasma vitamins shown in Table 2 for dementia patients and controls. There were significant differences in plasma levels A, C and E were reduced in a malnourished subgroup of AD patients.20 In the present study, detailed of the individual chain-breaking antioxidants b-carotene, lycopene, vitamins A, C, E, and also in serum assessment of nutritional status was not made, but an assessment was obtained from a history of cholesterol between dementia and control groups. adequate food intake (patient/carer) and measurement of haemoglobin and albumin levels as previously described.21 Subjects were living in the community with a carer, and those with an inadequate diet or low haemoglobin or albumin were excluded. Dementia subjects in the present study had apparently normal nutritional status yet significant deficiencies of antioxidants were observed. In a previous small study AD, patients were found to be deficient in vitamins A and E and b-carotene, while VaD patients were deficient in vitamin E and bcarotene.21 In another study, plasma vitamin C and E were decreased in subjects with dementia, while plasma b-carotene was increased in VaD and an increase in TAC was observed in both dementias.22 The increase in TAC was said to represent a response to increased free radical activity. No reference was made to nutritional status in that study. It is suggested that oxidative modification of low-density lipoprotein is a prerequisite for atherosclerosis,23 which in turn is a risk factor for VaD. Our findings of a reduced Vitamin A, C and E could be in keeping with such a hypothesis for atherosclerosis and resultant VaD. The present study supports the hypothesis that excessive free-radical activity occurs in dementia, particularly in VaD and AD, and is manifest as a decrease in plasma chain-breaking antioxidants, especially vitamins A, C and E. Vitamin E was significantly reduced in AD and VaD, but when corrected for serum cholesterol, the reduction was not significant. This may have been a reflection of Units mmol/l except cholesterol, urate and bilirubin, mmol/l; vitamin E/cholesterol, mmol/mmol;
and TAC, mmol/l vitamin C equivalents. Results compared using Kruskal-Wallis 1-way ANOVA. Abbreviations as Table 1 . Units mmol/l except urate, bilirubin, cholsterol, mmol/l; vitamin E/cholesterol, mmol/mmol; TAC mmol/l vitamin C equivalents. *p=0.03.
significantly increased cholesterol in the control in itself as membranes are a key site for freeradical injury. group resulting in lower corrected vitamin E levels. The relatively high cholesterol in the control group Studies of plasma chain-breaking antioxidants in Parkinson's disease have not shown any changes. was an unexpected and unexplained finding. One might have expected those subjects with vascular Plasma concentrations of vitamins A and E in 27 elderly Parkinson's disease patients were no different dementia to have a relatively increased cholesterol, and the AD group to have had increased cholesterol, from controls and while Vitamin C was observed to be significantly higher in Parkinson's disease, this through the effect of the over-representation of Apo e4. 24 was thought to be due to low levels in the control group.26 Conversely, it was observed that vitamin C It is also possible that medication could have affected the results. Many patients and controls were and E administration may slow disease progression in Parkinson's disease.5 on aspirin and treatments for stable ischaemic heart disease or hypertension, while PDem patients were Although there is much evidence for increased oxidation in the pathogenesis of Parkinson's dison L-dopa preparations (five on selegiline). It could be expected that aspirin and L-dopa preparations in ease,5,27,28 the present study demonstrated no deficiencies of plasma chain-breaking antioxidants in particular would have effects on antioxidant systems. This study was not of sufficient power to analyse for this disease. It is interesting that the PDem patients had significant decreases in plasma lycopene and these differences.
Decreased levels of specific antioxidants were not vitamin C, but no significant changes in vitamins A and E compared to controls. It may also be quite reflected in the overall measure of antioxidant capacity TAC. However, TAC is largely influenced significant that lycopene was reduced compared to VaD and AD. This may suggest some free-radical by urate19 which was not different between groups. These results indicate that TAC may not be a activity in PDem which is less intense than the other dementias and more intense than PD. Increased free satisfactory indirect measure of free-radical activity. Recently, another method for the simultaneous deterradical activity in PDem may reflect the effect of concomitant AD pathology that is known to co-exist minant of plasma and erythrocyte antioxidant status has been described.25 The test is based on the in this condition. Oxidation may not be the sole mechanism produsensitivity to haemolysis of an erythrocyte suspension on the introduction of a radical initiator and the cing neurodegeneration in the heterogeneous disorder of AD. However, it has been suggested as a volume of plasma inhibiting 50% of the haemolysis. The reliability of this method has yet to be confirmed possible mechanism for some of the 20 identified risk factors.29 Enzyme antioxidants, studied in postin pathological studies, and values are also influenced by plasma urate. There is the advantage of an mortem AD brain homogenates30-32 and in transgenic mice,33-35 provide further evidence of increased additional measurement of lipid membrane sensitivity to free-radical attack which may act as a control for oxidation. Several studies have also observed that both the deposition and the cytotoxicity of b-amyloid each plasma value, and this is an important measure 12. American Psychiatric Association Task Force on protein (BAP) seem to be mediated by free radicals.36- 
